A Prospective Multicenter Observational Study for Dacogen Treatment in Patients With Myelodysplastic Syndrome.
Phase of Trial: Phase IV
Latest Information Update: 26 Jul 2013
At a glance
- Drugs Decitabine (Primary)
- Indications Chronic myelomonocytic leukaemia; Myelodysplastic syndromes
- Focus Therapeutic Use
- Sponsors Janssen
- 30 Jul 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 29 Jul 2010 Actual end date (Jul 2010) added as reported by ClinicalTrials.gov.
- 09 Jan 2010 New trial record